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Figure 1. A schematic depicting possible interplay between insulin and 20E signaling in the control of Dro-
sophila growth and developmental timing
Nutrition promotes release of dILPs from the mNSC into the hemolymph. Thus the growth of the fat body and
other peripheral tissues, including the PG, is increased. The amount of dILP-stimulated growth of the PG
dictates the amount of 20E it releases. 20E directly inhibits fat body growth by reducing dILP-mediated PIP3
production and affects the growth of other peripheral tissues. In addition, 20E can signal that the larval critical
weight has been reached and trigger the onset of metamorphosis.
lin signaling and thus organismal growth
rate. So it seems that 20E is able to an-
tagonize the insulin signaling pathway in
larval tissues and therefore reduce growth.
Furthermore, depleting EcR specifically in
the fat body was sufficient to phenocopy
inhibition of insulin signaling in the PG, in-
dicating that the fat body is an important
target of 20E signaling, which may be able
to relay a growth-inhibitory signal to other
larval tissues.
Together, these papers show that there
is significant and complex crosstalk be-
tween the insulin and 20E signaling
pathways. Insulin signaling can increase
the levels of 20E produced by the PG;
20E in turn can act both to directly in-
hibit insulin signaling and growth in the
fat body (and likely other peripheral tis-
sues) and to promote developmental
progression and hence larval wandering
and metamorphosis (Figure 1). What is
the functional significance of these links?
They may provide a way of coupling
growth rate and developmental timing,
such that the same molecule (20E) can
limit tissue growth and induce metamor-
phosis. It may also ensure that in times
of low nutrition, development can be de-
It remains to be seen exactly how the
crosstalk between ecdysone and insulin
signaling occurs at a molecular level.
First, how do dILPs affect 20E levels?
Do they promote the synthesis, process-
ing, secretion, or stability of 20E in the
PG? Colombani et al. showed that ele-
vated insulin signaling in the PG in-
creases the levels of at least two en-
zymes that are required for ecdysteroid
synthesis, suggesting that the former
hypothesis may be true. Second, how
does 20E inhibit insulin signaling in the
fat body and other larval tissues? The
use of the tGPH reporter, which binds to
PIP3, indicates that the non-cell-autono-
mous effect mediated by 20E acts up-
stream in the insulin pathway and can
modulate PIP3 levels in the fat body cell
membrane. The proposed model pre-
dicts that systemic insulin signaling fluc-
tuates in response to changing 20E
levels during normal development. In-
deed, it has been shown that during the
last larval stage, the level of insulin sig-
naling starts off high but gradually de-
creases as development progresses and
20E levels rise (Rusten et al., 2004). It
will be interesting to know whether such
fluctuations also occur earlier in devel-
No doubt further complexities in the in-
terplay between insulin and 20E signaling
in the whole organism will be revealed by
future work. For the time being though,
the papers discussed here take our knowl-
edge further and reveal an elegant mech-
anism for coupling the control of growth
and developmental progression. It will
also be intriguing to see whether similar
links between control of growth and de-
velopmental progression exist in other or-
ganisms.
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Enlightening the adrenal gland
The secretion of glucocorticoid hormones is tightly regulated by the circadian clock and by negative humoral feedback
loops, both acting on the hypothalamic-pituitary gland-adrenal axis. However, a new study (Ishida et al., 2005 [this issue
of Cell Metabolism]) shows that light can influence the adrenal's glucocorticoid output by a more direct pathway.
opment and in other tissues. DOI 10.1016/j.cmet.2005.10.005278 CELL METABOLISM : NOVEMBER 2005
P R E V I E W SIt has been known for a long time that
plasma glucocorticoid hormone levels
follow robust daily oscillations, which
are driven by the master circadian clock
in the suprachiasmatic nucleus (SCN)
via the hypothalamic-pituitary gland-
adrenal axis. As a consequence, the
transcription of many glucocorticoid-
responsive genes in peripheral organs
may fluctuate during the day. However,
glucocorticoids may also act on the cir-
cadian expression of genes that are not
directly glucocorticoid sensitive, namely
by acting as timing cues for cell-autono-
mous clocks in peripheral tissues. The
paper by Ishida et al. (2005) suggests
that this synchronization could be ac-
complished by a novel pathway in which
light directly stimulates adrenal gluco-
corticoid synthesis and secretion via the
SCN and the splanchic nerve.
Glucocorticoids—cortisone in humans
and corticosterone in rodents—participate
in a dazzling array of physiological func-
tions. During starvation, they increase glu-
cose supply for the brain and other
tissues by promoting hepatic gluconeo-
genesis and by stimulating the breakdown
of lipids and proteins to metabolites that
can serve as substrates for gluconeo-
genesis. They act as immunosupressors
by stimulating T-lymphocyte apoptosis,
and as anti-inflammatory agents by in-
terfering with proinflammatory cytokine
secretion. Furthermore, they play impor-
tant roles in lung surfactant production,
bone homeostasis, mammary gland de-
velopment, and memory consolidation
(Miller and Tyrell, 1995). More recently,
glucocorticoid signaling has also been
shown to participate in the timing of cir-
cadian rhythms in peripheral cell types
and organs (Le Minh et al., 2001). Mice
homozygous for a glucocorticoid null al-
lele die shortly after birth due to respira-
tory failure (Cole et al., 1995).
Glucocorticoids are produced from
cholesterol in the adrenal cortex. Due to
their lipophilic nature, they can directly
diffuse into cells, where they activate the
glucocorticoid receptor by releasing it
from inactive, cytosolic complexes with
chaperones and immunophilins. The li-
gand bound receptor migrates to the nu-
cleus, binds to glucocorticoid-respon-
sive elements (GREs) within promoter or
enhancer regions, and, depending on
the protein-protein interactions it estab-
lishes with other transcription factors
such as cJun, cFos, NFkB, STATs, and
SMADs, can enhance or repress tran-
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l., 2004).
Given the critical functions glucocorti-
oids have in many physiological pro-
esses, the plasma levels of these hor-
ones are tightly regulated. Classically,
his control was believed to be exerted
xclusively by the central nervous sys-
em on the hypothalamic-pituitary-adre-
al (HPA) axis and by negative humoral
eedback loops within this axis. Thus, in-
uts from various brain regions, includ-
ng the suprachiasmatic nucleus harbor-
ng the central circadian timekeeper,
licit secretion of corticotropin-releasing
actor (CRF) from specialized neurons in
he hypothalamus. CRF then stimulates
he secretion of adrenocorticotropic hor-
one (ACTH) from corticotroph cells in
he pituitary gland, which in turn triggers
he synthesis and secretion of glucocor-
icoid hormones in the adrenal cortex.
ue to the influence of the circadian
lock on CRF secretion, glucocorticoid
evels oscillate with robust daily rhythms
n the plasma of most mammals, reaching
eak levels just before the onset of the
ctivity period. In addition, glucocorti-
oids repress their own synthesis through
wo negative feedback loops, by inhibiting
he synthesis of CRF in hypothalamic
eurons and ACTH in pituitary gland corti-
otrophs (Tronche et al., 1998).
Recent evidence, however, has sug-
ested that in response to dehydration,
he sympathetic nervous system can
timulate glucocorticoid secretion in the
drenal gland of rats directly via splanch-
ic nerve innervation. Such regulation
ight be of wide physiological signifi-
ance since glucocorticoid synthesis
as been documented in the absence of
levated ACTH levels in a wide variety of
ases—anorexia, depression, Alzheimer’s
isease, ischemic injury, and abdominal
r brain injury (Ulrich-Lai and Engeland,
002, and references therein).
Now, an elegant study by Okamura
nd coworkers adds a new twist to this
ympathetic connection (Ishida et al.,
005). The mPer1 gene is believed to be
core oscillating component of the cir-
adian clockwork circuitry, and it is also
elieved to participate in the phase re-
etting of these clocks. Light pulses de-
ivered to animals that have been kept
or several days in constant darkness
rigger a burst of mPer1 expression in
he suprachiasmatic nuclei, and such
ight-induced mPER1 surges cause phase
hifts in the central clock. Using an ultra-
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oensitive, two-dimensional photon-count-
ng camera and mPer1-luc transgenic
ice in which firefly luciferase is ex-
ressed from the mPer1 promoter, Is-
ida et al. (2005) monitored mPer1 ex-
ression in abdominal organs. When
xamining anesthetized mPer1-luc mice
xposed to light, the authors found that
Per1 expression was strongly induced
n the adrenal gland shortly after the light
reatment. Subsequent microarray anal-
sis showed that this surge of mPer1 ex-
ression was accompanied by the ex-
ression of other immediate early genes,
uch as CREM (cAMP responsive ele-
ent modulator) and members of the
r4a and Nr5a nuclear receptor subfam-
lies. More importantly, light potently in-
uced the production of corticosterone
n the adrenal cortex and elicited a rise
f corticosterone concentrations in both
he blood plasma and the cerebrospinal
luid. Lesion experiments indicated that
oth the SCN and the adrenal nerve are
equired for light-induced corticosterone
ecretion. However, as light had no influ-
nce on ACTH plasma levels, the stimu-
ation of adrenal cortex activity by light
oes not appear to involve the HPA axis.
The physiological significance of this
ew pathway, which is schematically
utlined alongside the more classical
ne in Figure 1, is still open to specula-
ions. Conceivably, the light-induced in-
rease in corticosterone secretion could
articipate in the phase resetting of cir-
adian oscillators throughout the body.
onsistent with this hypothesis, the glu-
ocorticoid receptor is present in all pe-
ipheral tissues and in most brain re-
ions. Interestingly, however, it is absent
rom the suprachiasmatic nucleus itself,
erhaps preventing the master clock
rom being influenced by its own com-
ands (Balsalobre et al., 2000). In pe-
ipheral organs and fibroblasts grown in
issue culture, mPer1 expression and
ubsequent phase shifts in circadian
ene expression are induced by a large
ariety of chemical signals, including the
lucocorticoid receptor agonist dex-
methasone (Balsalobre et al., 2000).
oreover, Cushing’s syndrome patients,
ho experience a wide range of physio-
ogical problems due to constitutively el-
vated cortisone levels, also suffer from
leep-related circadian abnormalities
Friess et al., 1995).
If a light-induced pathway were also
perative in humans, a question that279
P R E V I E W SFigure 1
.
Model of humoral and light-induced regulation of glucocorticoid secretion
In the classical pathway (indicated by blue arrows), hypothalamic neurons producing corticotropin-releasing factor (CRF) receive input from afferent neurons in the
cortex (dotted blue lines) and other brain regions reacting to physical and psychic stress (abbreviation of brain structures: SCN, suprachiasmatic nucleus; Hy, Hypothala-
mus; T, Thalamus, Cb cerebellum; PG, pituitary gland). These neurons also receive input from the SCN, which controls the circadian secretion of CRF. The phase of
the SCN master clock is reset every day by light inputs from the retina via the retino-hypothalamic tract (blue arrow from eye to SCN). CRF triggers the production and
release of ACTH from the pituitary gland, which in turn elicits the production and release of glucocorticoid hormones from the adrenal cortex (C). In the new pathway
discovered by Ishida et al. (2005) (red arrows), light can induce the synthesis and secretion of glucocorticoids more directly through connections of the SCN with the
sympathetic nervous system innervating the adrenal medulla (M). Epinephrine, secreted by the medulla, triggers the expression of mPer1 and other immediate early
genes (IEGs) in the cortex, perhaps via the activation of CREB (cyclic AMP response element binding protein) through MAP kinase-mediated phosphorylation (P). Some
of the IEG products affect the accumulation and/or activity of steroidogenic enzymes, leading to an enhanced secretion of glucocorticoid hormones into the bloodstream
(green arrow) and the activation of glucocorticoid receptor (GR) in many peripheral organs (e.g., liver, as shown here). mPer1, a direct target gene of GR, is induced,
and the surge of mPER1 accumulation resets the clock in peripheral organs. High levels of glucocorticoids inhibit the synthesis of CRF and ACTH in the hypothalamus
and the pituitary gland, respectively (green repression bars).could readily be examined by recording
plasma cortisone levels after light expo-
sure, it would be tempting to speculate
that cortisone-mediated synchronization
of peripheral circadian clocks would be
one of the beneficial effects light therapy
has on patients affected by seasonal af-
fective disorder (SAD). It might also ex-
plain why bright light therapy can aid pa-
tients with other depressive disorders
not typically associated with the circa-
dian clock (e.g., major depressive disor-
der and bipolar disorder) (Kripke, 1998).
In short, from the perspectives of both
chronobiologists and clinicians, sympa-
thetic signaling to the adrenal gland
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